Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03094364 · ClinicalTrials.gov registry record · NA
Video Game-based Therapy for Arm Weakness In Progressive Multiple Sclerosis
A NA study, sponsored by University of Massachusetts, Lowell.
- Completed
- Registry status
- NA
- Development phase
- 31
- Enrollment target
NCT03094364: Completed NA study, sponsored by University of Massachusetts, Lowell.
NCT03094364 is a NA study that has completed, run by University of Massachusetts, Lowell. The registered enrollment target is 31 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03094364, a NA study, has completed, sponsored by University of Massachusetts, Lowell.
- COMPLETED
- Registry status
- NA
- Development phase
- 31 participants
- Enrollment target
Study Summary
Participants will receive intensive therapy through a video game in their own homes for 1 month. The game is operated by movements of the body (no controller needed) and acts like a virtual therapist. Participants will agree to play the game for 30 hours. They will also receive 4 home visits from a therapist designed to increase use of their arm for daily activities that are important to them. Participants will also receive a smart watch that will measure use of their weaker arm and alert them when their arm is not participating in activities. Arm strength and function will be measured before and after the therapy program.
Primary Outcome
Devices to monitor upper extremity movement throughout treatment
Interventions
- BEHAVIORAL Gaming CI Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 31 participants |
| Start Date | 2015-11 |
| Est. Completion | 2018-10-31 |
| Phase | NA |
What the finished NCT03094364 record still lists
NCT03094364 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 31 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 1 intervention - of which Gaming CI Therapy is the first listed.
NCT03094364 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03094364 about?
NCT03094364 is a clinical study titled "Video Game-based Therapy for Arm Weakness In Progressive Multiple Sclerosis". Participants will receive intensive therapy through a video game in their own homes for 1 month. The game is operated by movements of the body (no controller needed) and acts like a virtual therapist. Participants will agree to play the game for 30 hours. They will also receive 4 home visits from a ...
What is the current status of trial NCT03094364?
This trial is currently completed. It is a NA study. The enrollment target is 31 participants. The study started on 2015-11. Estimated completion is 2018-10-31.
What interventions are being tested in trial NCT03094364?
The interventions under investigation include: Gaming CI Therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT03094364?
This trial is sponsored by University of Massachusetts, Lowell, which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03094364's enrollment target sits among peer trials
31 1592nd of 2000 higher than 408 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02932618 · 31 participants · Phase 3
A Study of Recombinant Von Willebrand Factor (rVWF) With or Without ADVATE in Children With Severe Von Willebrand Disease (VWD)
- NCT03482297 · 31 participants · Phase 1
Automated Abdominal Binder for Orthostatic Hypotension
- NCT04016389 · 31 participants · NA
FIGO 2018 Stage IB2 Cervical Cancer Treated With Neoadjuvant Chemotherapy Followed by Fertility Sparing Surgery
- NCT04211675 · 31 participants · Phase 1
NK Cells Infusions With Irinotecan, Temozolomide, and Dinutuximab
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia